Heme oxygenase−1 in thyroid cancer: a context-dependent regulator
Journal of Endocrinological Investigation · 17.08.2026
DOI: 10.1007/s40618-026-03025-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 17.08.2026. Verfasst von Exequiel Gonzalo Alonso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología, Bioquímica y Farmacia (UNS), Laboratorio de Biología del Cáncer, Instituto de Investigaciones Bioquímicas de Bahía Blanca (…. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Heme oxygenase-1 (HO-1) catalyzes the rate-limiting step of heme degradation and has traditionally been regarded as a cytoprotective, antioxidant enzyme. However, HO-1 also influences tumour behaviour through activities independent of its catalytic function. This review aims to integrate current evidence on HO-1 regulation and function in thyroid cancer and to examine how its context-dependent actions may influence tumour biology and therapeutic response. METHODS: We review available preclinical and clinical evidence on HO-1 in thyroid cancer, with particular emphasis on oxidative stress, metabolic reprogramming, tumour progression, subcellular localization, and the potential therapeutic implications of HO-1 modulation. RESULTS: Current evidence links HO-1 to proliferation, redox homeostasis, and metabolic flexibility in thyroid cancer. Importantly, its effects are not uniform but appear to depend on tumour subtype, cellular context, structural state, and intracellular compartment. In particular, nuclear HO-1 may mediate non-enzymatic functions associated with more aggressive and treatment-refractory phenotypes. Although modulation of HO-1 has potential therapeutic relevance, supporting evidence remains predominantly preclinical. CONCLUSION: HO-1 should not be considered solely as an antioxidant enzyme in thyroid cancer, but rather as a context-dependent regulator whose functional output is shaped by tumour context and subcellular localization. Further clinical validation is required to establish its prognostic and therapeutic relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Biología, Bioquímica y Farmacia (UNS), Laboratorio de Biología del Cáncer, Instituto de Investigaciones Bioquímicas de Bahía Blanca (INIBIBB), Universidad Nacional del Sur (UNS)-CONICET, 8000, Bahía Blan…
Zitieren
APA
Alonso, E. G., Mascaró, M., Schweitzer, K., Clemente, V., Curino, A. C., & Facchinetti, M. M. (2026). Heme oxygenase−1 in thyroid cancer: a context-dependent regulator. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-026-03025-9
Vancouver
Alonso EG, Mascaró M, Schweitzer K, Clemente V, Curino AC, Facchinetti MM. Heme oxygenase−1 in thyroid cancer: a context-dependent regulator. Journal of Endocrinological Investigation. 2026. doi:10.1007/s40618-026-03025-9
BibTeX
@article{Alonso2026,
author = {Alonso, Exequiel Gonzalo and Mascaró, Marilina and Schweitzer, Karen and Clemente, Valentina and Curino, Alejandro Carlos and Facchinetti, María Marta},
title = {Heme oxygenase−1 in thyroid cancer: a context-dependent regulator},
journal = {Journal of Endocrinological Investigation},
year = {2026},
doi = {10.1007/s40618-026-03025-9}
}
EUVIMED